SEARCH   
MEMBER LOGIN    

Contract Pharmaceutical Research Services in the US: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Contract Pharmaceutical Research Services Market Research Report | Life Sciences | Laboratory Services | Mar 2015

Doctor approved: The shifting landscape in drug production has facilitated rapid industry growth

The Contract Pharmaceutical Research Services market research report provides key industry analysis and industry statistics, measures market size, analyzes current and future industry trends and shows market share for the industry’s largest companies. IBISWorld publishes the largest collection of industry reports so you can see an industry’s supply chain, economic drivers and key buyers and markets.

Report Snapshot
Market Share of Companies
Covance Inc. Covance Inc. market share
Paraxel International Paraxel International market share
Quintiles Transnational Quintiles Transnational market share
Industry Statistics & Market Size
Revenue
$9bn
Annual Growth 10-15
9.4%
Annual Growth 15-20
Purchase to read more
Profit
Purchase to read more
Employment
14,291
Businesses
221
Industry Analysis & Industry Trends

The Contract Pharmaceutical Research Services industry experienced hefty growth in the past five years. Moreover, the industry is anticipated to continue its growth streak in the five years to 2020. Rising global competition during this time will limit revenue growth from achieving the double-digit rates that the industry enjoyed in the previous five years. Still, the industry's rise to prominence will transform drug development and production, securing its place in the pharmaceutical value chain.... purchase to read more

Industry Report - Industry SWOT Analysis Chapter

The Contract Pharmaceutical Research Services industry is in the growth stage of its life cycle. Industry value-added (IVA), a measure of the industry's contribution to the overall economy, is expected to increase at an annualized 6.0% in the 10 years to 2020; meanwhile, US GDP is expected to increase at an annualized 2.5% in the same period. Industry operators are claiming a larger share of pharmaceutical companies' research and development spending, as drug producers increasingly focus on cost efficiency and quicker trial programs in the face of rising competition from generics and regulation under healthcare reform.

The industry's rapid rise comes with major shifts in downstream pharmaceutical manufacturing... purchase to read more

 


Industry ProductsRelated ReportsTable of Contents

What is the Contract Pharmaceutical Research Services Industry?

The industry provides a range of research and development services to pharmaceutical manufacturers, including laboratory testing, preclinical and clinical trials, commercialization and post-market surveillance.

Industry Products
Central labPhase IPreclinicalPhase II-IV
 
Industry Activities
Conduct laboratory testing and biostatistical analysisConduct preclinical trialsConduct early-stage and late-stage clinical trialsProvide consulting services related to regulation Provide pharmacovigilance


View Sample
Quote
Select Clients